GI Tract Flashcards
Different types and uses of GI drugs
1- For peptic ulcer
2- For chemo-induced emesis control
3- Antidiarrheals
4- Laxatives
5- For IBDs
Peptic ulcer causes
1- NSAIDs
2- H. Pylori (70% of gastric, 90% of duodenal)
3- Increased acid
4- Inadequate mucosal defense
Peptic ulcer treatment approaches
1- Antimicrobial: For H. Pylori
2- Decrease acid secretion: H2 antagonists & proton pump inhibitors
3- Neutralize gastric acid: Non-absorbable antacids
4- Enhance mucosal defense: Misoprostol, sucralfate
5- Stop smoking
Decrease gastric acid secretion
- H2 receptor antagonist (Inhibition of H/K-ATPase proton pump)
- Prostaglandins
- Antimuscarinic agents (Anticholinergics)
H2 receptor antagonist
Mechanism, Use time, Examples
- Block binding of histamine to H2 receptor
- So reduce cAMP concentration
- So decrease secretion of acid
- Basal, food stimulated & nocturnal secretion decrease after single dose
- More acid at nights so used mostly at nights
- -TIDINE:
- Cimetidine
- Ranitidine
- Famotidine
- Niatidine
Histamine effects
- Adenylyl cyclase activation:
- Increases cAMP
- Activates PKA
What does PKA do?
- Phosphorylation of skeletal proteins
- Moves H-K ATPase from cytoplasm to membrane
Acetylcholine & Gastrin on calcium
Increases intracellular Ca2+
Muscarinic receptor (Acethylcholine)
Increases 4 things:
- Peristalsis
- Secretions
- Sphincter opening
- Smooth muscle contraction
Cimetidine
mechanism, side effects
- Blocks H2 receptor, decreases acid
Side effects: - Tachycardia
- Cirrhosis (overdose with other drugs)
- Gynecomastia (in men)
- Galactorrhea (in women)
- Bleeding w/ Warfarin
Nizatidine
First pass effect
- Less affected by first pass effect
First pass effect:
Drug destroyed in liver before reaching circulation
Therefore less oral form & more injection
Anti-acids
Example, mechanism
- Al(OH)3 constipation
- Mg(OH)2 diarrhea
- Neutralize acid, increase pH
Protectants
Examples
- Carbenoxolone
- Sucralfate
Proton pump inhibitors
PPI
Examples, Mechanism, Clinical use, Half life
- Omeprazol, Pantoprazol, Esomeprazol
- Inhibit H-K ATPase pump in parietal cells
- Bioavailability decreases by 50% with food (mornings 1h before breakfast)
Clinical use: - Reflux
- Peptic ulcers
- Ulcer from H. pylori
- NSAIDs ulcer
- Peptic ulcer prevention
- Before stomach tumor treatment
Half life: 1-1.5h but 24h effect - Stronger than H2 blockers, almost 0 acid
- Negative feedback causes histamin, gastrin & acethylcholine increase
PPI side effects
- B12 decrease in long term
- Decrease mineral absorption
- Increase lung & GI infection (destroying acid wall)